Literature DB >> 21540005

Brugada-type electrocardiogram in the Taiwanese population--is it a risk factor for sudden death?

Jyh-Ming Jimmy Juang1, Wei-Lian Phan, Pau-Chung Chen, Ling-Ping Lai, Min-Hsi Tsai, Jou-Wei Lin, Pi-Hsun Cheng, Wei-Yih Chiu, Bor-Wen Cheng, Juey-Jen Hwang, Chuen-Den Tseng, Kwan-Lih Hsu, Yung-Zu Tseng, Jiunn-Lee Lin, Fu-Tien Chiang.   

Abstract

BACKGROUND/
PURPOSE: People receive electrocardiogram (ECG) examination for various reasons in a hospital setting. An important clinical practice issue may be that cardiologists need to be consulted for Brugada-type ECGs identified through routine screening. We investigated the prevalence and prognosis of patients with Brugada-type ECG in a hospital-based population in an attempt to improve the management of these patients.
METHODS: In 20,562 patients seeking medical care for non-cardiovascular reasons, 74,955 ECGs were performed from December 1999 to February 2001. The diagnostic criteria for Brugada-like ECG from the European Society of Cardiology were used. International Statistical Classification of Diseases codes and city residents' records were documented to indicate the reasons for visiting clinics or hospitalization and mortality outcome. Medical records were reviewed and telephone interviews were conducted.
RESULTS: Twenty-six (0.13%) of the 20,562 patients were confirmed to have Brugada-type ECGs. None of these patients had ever experienced syncope, near syncope or sudden cardiac death. After 57.1 ± 15.8 months of follow-up, there were four deaths out of the 26 patients with Brugada-type ECG (15.4%, 95% CI: 1.53-2.9%) compared with 2899 of those without (14.1%, 95% CI: 13.6-14.5%; p=0.89, log-rank test). Neither sudden cardiac death (p=0.61) nor hospitalized death (p=0.55) was different between patients with and without Brugada-type ECG.
CONCLUSION: Patients with Brugada-type ECGs are not rare in a hospital-based population. The presence of Brugada-type ECGs in patients without syncope or sudden cardiac death was not associated with hospitalized mortality.
Copyright © 2011 Formosan Medical Association & Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21540005     DOI: 10.1016/S0929-6646(11)60035-1

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  9 in total

1.  Prevalence of Atrial Fibrillation in Patients with Brugada Syndrome in Taiwan.

Authors:  Jyh-Ming Jimmy Juang; Ching-Yu Chen; Yen-Bin Liu; Lian-Yu Lin; Wen-Jone Chen; Ling-Ping Lai; Chia-Ti Tsai; Jiunn-Lee Lin
Journal:  Acta Cardiol Sin       Date:  2013-07       Impact factor: 2.672

Review 2.  Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Authors:  Charles Antzelevitch; Bence Patocskai
Journal:  Curr Probl Cardiol       Date:  2015-06-11       Impact factor: 5.200

3.  Worldwide Prevalence of Brugada Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Wasawat Vutthikraivit; Pattara Rattanawong; Prapaipan Putthapiban; Weera Sukhumthammarat; Prin Vathesatogkit; Tachapong Ngarmukos; Ammarin Thakkinstian
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

4.  Utilizing multiple in silico analyses to identify putative causal SCN5A variants in Brugada syndrome.

Authors:  Jyh-Ming Jimmy Juang; Tzu-Pin Lu; Liang-Chuan Lai; Chia-Hsiang Hsueh; Yen-Bin Liu; Chia-Ti Tsai; Lian-Yu Lin; Chih-Chieh Yu; Juey-Jen Hwang; Fu-Tien Chiang; Sherri Shih-Fan Yeh; Wen-Pin Chen; Eric Y Chuang; Ling-Ping Lai; Jiunn-Lee Lin
Journal:  Sci Rep       Date:  2014-01-27       Impact factor: 4.379

Review 5.  Brugada syndrome in children - Stepping into unchartered territory.

Authors:  Shashank P Behere; Steven N Weindling
Journal:  Ann Pediatr Cardiol       Date:  2017 Sep-Dec

6.  A meta-analytic review of prevalence for Brugada ECG patterns and the risk for death.

Authors:  Xiao-Qing Quan; Song Li; Rui Liu; Kai Zheng; Xiao-Fen Wu; Qiang Tang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

7.  GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death.

Authors:  Jyh-Ming Jimmy Juang; Anna Binda; Shyh-Jye Lee; Juey-Jen Hwang; Wen-Jone Chen; Yen-Bin Liu; Lian-Yu Lin; Chih-Chieh Yu; Li-Ting Ho; Hui-Chun Huang; Ching-Yu Julius Chen; Tzu-Pin Lu; Liang-Chuan Lai; Shih-Fan Sherri Yeh; Ling-Ping Lai; Eric Y Chuang; Ilaria Rivolta; Charles Antzelevitch
Journal:  EBioMedicine       Date:  2020-07-07       Impact factor: 8.143

Review 8.  Brugada syndrome: a fatal disease with complex genetic etiologies - still a long way to go.

Authors:  Yeda Wu; Mei Ai; Adham Sameer A Bardeesi; Lunwu Xu; Jingjing Zheng; Da Zheng; Kun Yin; Qiuping Wu; Liyong Zhang; Lei Huang; Jianding Cheng
Journal:  Forensic Sci Res       Date:  2017-07-05

Review 9.  Brugada syndrome: should we be screening patients before prescribing psychotropic medication?

Authors:  Azizah Attard; Claire Stanniland; Stephen Attard; Andrew Iles; Kim Rajappan
Journal:  Ther Adv Psychopharmacol       Date:  2022-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.